{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T05:10:03Z","timestamp":1721711403409},"reference-count":35,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.249.1","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:14:51Z","timestamp":1568067291000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Free Protein S Is Correlated with Disease Activity, but not with Subclinical Atherosclerosis among Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study"],"prefix":"10.1620","volume":"249","author":[{"given":"Ju-Yang","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ajou University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Anderson, H.A., Maylock, C.A., Williams, J.A., Paweletz, C.P., Shu, H. &amp; Shacter, E. (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. <i>Nat. Immunol.<\/i>, 4, 87-91."},{"key":"2","unstructured":"Bombardier, C., Gladman, D.D., Urowitz, M.B., Caron, D. &amp; Chang, C.H. (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. <i>Arthritis Rheum.<\/i>, 35, 630-640."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cacciapaglia, F., Zardi, E.M., Coppolino, G., Buzzulini, F., Margiotta, D., Arcarese, L., Vadacca, M., Amoroso, A. &amp; Afeltra, A. (2009) Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. <i>Lupus<\/i>, 18, 249-256.","DOI":"10.1177\/0961203308097571"},{"key":"4","doi-asserted-by":"crossref","unstructured":"de Leeuw, K., Freire, B., Smit, A.J., Bootsma, H., Kallenberg, C.G. &amp; Bijl, M. (2006) Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. <i>Lupus<\/i>, 15, 675-682.","DOI":"10.1177\/0961203306069972"},{"key":"5","unstructured":"El Beshlawy, A., Alaraby, I., Abou Hussein, H., Abou-Elew, H.H. &amp; Mohamed Abdel Kader, M.S. (2010) Study of protein C, protein S, and antithrombin III in newborns with sepsis. <i>Pediatr. Crit. Care Med.<\/i>, 11, 52-59."},{"key":"6","unstructured":"Engesser, L., Broekmans, A.W., Briet, E., Brommer, E.J. &amp; Bertina, R.M. (1987) Hereditary protein S deficiency: clinical manifestations. <i>Ann. Intern. Med.<\/i>, 106, 677-682."},{"key":"7","unstructured":"Esdaile, J.M., Abrahamowicz, M., Grodzicky, T., Li, Y., Panaritis, C., du Berger, R., Cote, R., Grover, S.A., Fortin, P.R., Clarke, A.E. &amp; Senecal, J.L. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. <i>Arthritis Rheum.<\/i>, 44, 2331-2337."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Gheita, T.A., Bassyouni, I.H. &amp; Bassyouni, R.H. (2012) Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. <i>J. Clin. Immunol.<\/i>, 32, 1279-1286.","DOI":"10.1007\/s10875-012-9743-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gladman, D.D., Urowitz, M.B., Goldsmith, C.H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J.G., Isenberg, D.A., Kalunian, K., Nived, O., Petri, M., Sanchez-Guerrero, J., Snaith, M. &amp; Sturfelt, G. (1997) The reliability of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. <i>Arthritis Rheum.<\/i>, 40, 809-813.","DOI":"10.1002\/art.1780400506"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Jung, J.Y., Kim, H.A., Lee, H.Y. &amp; Suh, C.H. (2019) Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: a prospective 4 year follow-up study. <i>Int. J. Rheum. Dis.<\/i>, 22, 1410-1418.","DOI":"10.1111\/1756-185X.13588"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Jung, J.Y., Koh, B.R., Bae, C.B., Kim, H.A. &amp; Suh, C.H. (2014) Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus. <i>Lupus<\/i>, 23, 1517-1522.","DOI":"10.1177\/0961203314544185"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kristoffersen, A.H., Petersen, P.H., Roraas, T. &amp; Sandberg, S. (2017) Estimates of within-subject biological variation of protein C, antithrombin, protein S free, protein S activity, and activated protein C resistance in pregnant women. <i>Clin. Chem.<\/i>, 63, 898-907.","DOI":"10.1373\/clinchem.2016.265900"},{"key":"13","unstructured":"Lendak, D., Mihajlovic, D., Mitic, G., Ubavic, M., Novakov-Mikic, A., Boban, J. &amp; Brkic, S. (2018) Complement component consumption in sepsis correlates better with hemostatic system parameters than with inflammatory biomarkers. <i>Thromb. Res<\/i>., 170, 126-132."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Levine, J.S., Subang, R., Setty, S., Cabrera, J., Laplante, P., Fritzler, M.J. &amp; Rauch, J. (2014) Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus. <i>Lupus<\/i>, 23, 752-768.","DOI":"10.1177\/0961203314525676"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Margery-Muir, A.A., Bundell, C., Wetherall, J.D., Whidborne, R., Martinez, P. &amp; Groth, D.M. (2018) Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort. <i>Lupus<\/i>, 27, 1687-1696.","DOI":"10.1177\/0961203318787039"},{"key":"16","unstructured":"Marlar, R.A. &amp; Gausman, J.N. (2011) Protein S abnormalities: a diagnostic nightmare. <i>Am. J. Hematol.<\/i>, 86, 418-421."},{"key":"17","doi-asserted-by":"crossref","unstructured":"McMahon, M., Skaggs, B.J., Grossman, J.M., Sahakian, L., Fitzgerald, J., Wong, W.K., Lourenco, E.V., Ragavendra, N., Charles-Schoeman, C., Gorn, A., Karpouzas, G.A., Taylor, M.B., Watson, K.E., Weisman, M.H., Wallace, D.J., et al. (2014) A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. <i>Arthritis Rheumatol.<\/i>, 66, 130-139.","DOI":"10.1002\/art.38204"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Mihajlovic, D., Brkic, S., Lendak, D., Novakov Mikic, A., Draskovic, B. &amp; Mitic, G. (2017) Endogenous thrombin potential as marker of procoagulant response that can be useful in early stage of sepsis. <i>Blood Coagul. Fibrinolysis<\/i>, 28, 460-467.","DOI":"10.1097\/MBC.0000000000000622"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Mu, L., Hao, Y., Fan, Y., Huang, H., Yang, X., Xie, A., Zhang, X., Ji, L., Geng, Y. &amp; Zhang, Z. (2018) Mortality and prognostic factors in Chinese patients with systemic lupus erythematosus. <i>Lupus<\/i>, 27, 1742-1752.","DOI":"10.1177\/0961203318789788"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Munoz, L.E., van Bavel, C., Franz, S., Berden, J., Herrmann, M. &amp; van der Vlag, J. (2008) Apoptosis in the pathogenesis of systemic lupus erythematosus. <i>Lupus<\/i>, 17, 371-375.","DOI":"10.1177\/0961203308089990"},{"key":"21","unstructured":"Naqvi, T.Z. &amp; Lee, M.S. (2014) Carotid intima-media thickness and plaque in cardiovascular risk assessment. <i>JACC Cardiovasc. Imaging<\/i>, 7, 1025-1038."},{"key":"22","unstructured":"Petri, M., Orbai, A.M., Alarcon, G.S., Gordon, C., Merrill, J.T., Fortin, P.R., Bruce, I.N., Isenberg, D., Wallace, D.J., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Bae, S.C., Hanly, J.G., Sanchez-Guerrero, J., et al. (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. <i>Arthritis Rheum.<\/i>, 64, 2677-2686."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Pintao, M.C., Ribeiro, D.D., Bezemer, I.D., Garcia, A.A., de Visser, M.C., Doggen, C.J., Lijfering, W.M., Reitsma, P.H. &amp; Rosendaal, F.R. (2013) Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study. <i>Blood<\/i>, 122, 3210-3219.","DOI":"10.1182\/blood-2013-04-499335"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Recarte-Pelz, P., Tassies, D., Espinosa, G., Hurtado, B., Sala, N., Cervera, R., Reverter, J.C. &amp; de Frutos, P.G. (2013) Vitamin K-dependent proteins GAS6 and protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. <i>Arthritis Res. Ther.<\/i>, 15, R41.","DOI":"10.1186\/ar4199"},{"key":"25","unstructured":"Roman, M.J., Shanker, B.A., Davis, A., Lockshin, M.D., Sammaritano, L., Simantov, R., Crow, M.K., Schwartz, J.E., Paget, S.A., Devereux, R.B. &amp; Salmon, J.E. (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. <i>N. Engl. J. Med.<\/i>, 349, 2399-2406."},{"key":"26","unstructured":"Rothlin, C.V. &amp; Lemke, G.(2010) TAM receptor signaling and autoimmune disease. <i>Curr. Opin. Immunol.<\/i>, 22, 740-746."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Suh, C.H., Hilliard, B., Li, S., Merrill, J.T. &amp; Cohen, P.L. (2010) TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. <i>Arthritis Res. Ther.<\/i>, 12, R146.","DOI":"10.1186\/ar3088"},{"key":"28","unstructured":"Suleiman, L., Negrier, C. &amp; Boukerche, H. (2013) Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. <i>Crit. Rev. Oncol. Hematol.<\/i>, 88, 637-654."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Tabib, Y., Jaber, N.S., Nassar, M., Capucha, T., Mizraji, G., Nir, T., Koren, N., Aizenbud, I., Maimon, A., Eli-Berchoer, L., Wilensky, A., Burstyn-Cohen, T. &amp; Hovav, A.H. (2018) Cell-intrinsic regulation of murine epidermal Langerhans cells by protein S. <i>Proc. Natl. Acad. Sci. USA<\/i>, 115, E5736-E5745.","DOI":"10.1073\/pnas.1800303115"},{"key":"30","doi-asserted-by":"crossref","unstructured":"van der Meer, J.H., van der Poll, T. &amp; van\u2019t Veer, C. (2014) TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. <i>Blood<\/i>, 123, 2460-2469.","DOI":"10.1182\/blood-2013-09-528752"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Winberg, L.K., Nielsen, C.H. &amp; Jacobsen, S. (2017) Surface complement C3 fragments and cellular binding of microparticles in patients with SLE. <i>Lupus Sci. Med.<\/i>, 4, e000193.","DOI":"10.1136\/lupus-2016-000193"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wu, C.S., Hu, C.Y., Tsai, H.F., Chyuan, I.T., Chan, C.J., Chang, S.K. &amp; Hsu, P.N. (2014) Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis. <i>Rheumatol. Int.<\/i>, 34, 625-629.","DOI":"10.1007\/s00296-013-2882-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wu, J., Ekman, C., Jonsen, A., Sturfelt, G., Bengtsson, A.A., Gottsater, A., Lindblad, B., Lindqvist, E., Saxne, T. &amp; Dahlback, B. (2011) Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. <i>Arthritis Res. Ther.<\/i>, 13, R62.","DOI":"10.1186\/ar3316"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Zhu, H., Sun, X., Zhu, L., Hu, F., Shi, L., Fan, C., Li, Z. &amp; Su, Y. (2014) Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus. <i>Lupus<\/i>, 23, 624-634.","DOI":"10.1177\/0961203314520839"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zizzo, G., Guerrieri, J., Dittman, L.M., Merrill, J.T. &amp; Cohen, P.L. (2013) Circulating levels of soluble MER in lupus reflect M2c activation of monocytes\/macrophages, autoantibody specificities and disease activity. <i>Arthritis Res. Ther.<\/i>, 15, R212.","DOI":"10.1186\/ar4407"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/249\/1\/249_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T04:55:39Z","timestamp":1721710539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/249\/1\/249_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.249.1","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}